Biorasi
Biorasi is a privately held, full-service contract research organization founded in 2002, serving small biotech and mid-sized biopharma sponsors with complex clinical trials across neurology, nephrology, dermatology, oncology, and cell therapy in 48 countries.
- Company typePrivate
- Founded2002
- HeadquartersHollywood, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Biorasi does
Biorasi is a privately held, full-service contract research organization (CRO) founded in 2002 and headquartered in Aventura, Florida, with wholly-owned operating subsidiaries in Germany (Biorasi GmbH) and India (Biorasi Clinical Services Pvt. Ltd.). The company delivers end-to-end clinical trial management services to small biotech and mid-sized biopharma sponsors across neurology, nephrology, dermatology, oncology, and cell therapy therapeutic areas, operating in 48 countries with reach to 65% of the global population. Biorasi has contributed to five FDA approvals over the last seven years and reports 200+ completed global studies and 2,258 initiated trial sites.
The company's service portfolio spans full-service clinical trial management, trial rescue and recovery, data sciences and biometrics, clinical monitoring, safety and pharmacovigilance, AI-powered feasibility, and quality assurance. Core technology assets include the proprietary TALOS project management system and the Beeline sponsor-facing portal, which delivers 15 real-time KPI dashboards covering query trends, site activation, enrollment versus projections, protocol deviations, demographics, and AE/SAE analysis. Strategic technology partnerships with IBM Watson Health (Clinical Development platform), Ryght AI (AI-driven feasibility, site digital twins, agentic copilots), Flatiron Health (EHR-to-EDC integration), and Quotient Sciences (early-phase clinical development, announced October 2025) extend the platform's capabilities.
Biorasi monetizes through custom project-based contracts for complex clinical trials, sold via direct enterprise sales engagement without resellers or distributors. Pricing is bespoke by trial complexity, therapeutic area, geographic scope, and service bundle, with multi-year contract cadence. The company is backed by RLH Equity Partners, which leads its Board of Directors; in March 2026, COO Melissa Alesse was elevated to President while former CEO Chris O'Brien transitioned to the Board, signaling a planned succession under PE ownership.
Biorasi firmographics
Firmographics- Name
- Biorasi
- Legal name
- Biorasi, LLC
- Website
- http://www.biorasi.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Biorasi is a privately held, full-service contract research organization founded in 2002, serving small biotech and mid-sized biopharma sponsors with complex clinical trials across neurology, nephrology, dermatology, oncology, and cell therapy in 48 countries.
- Ownership category
- akta.pro rank
Biorasi industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Biorasi is headquartered
LocationHeadquarters
- HQ city
- Hollywood
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Biorasi business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Research Organization Services: Full-service CRO providing clinical trial management and execution services to pharmaceutical and biotech sponsors. Services include trial rescue, data sciences, clinical monitoring, safety and pharmacovigilance, feasibility, and quality assurance. Revenue generated through project-based contracts for complex clinical trials across neurology, nephrology, dermatology, oncology, and cell therapy therapeutic areas.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Full-Service CRO Engagement |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Biorasi product offering
Product offeringCore offering
Biorasi is a full-service contract research organization (CRO) that manages and executes complex clinical trials for small biotech and mid-sized biopharma sponsors. It delivers end-to-end services — including trial rescue, clinical monitoring, data sciences, safety and pharmacovigilance, feasibility, and quality assurance — powered by its proprietary TALOS project management system and Beeline real-time sponsor portal. The company specializes in neurology, nephrology, dermatology, oncology, and cell therapy.
Product overview
Biorasi is a full-service contract research organization (CRO) providing end-to-end clinical trial services for complex studies. The core offering is built on proprietary TALOS™ project management system enabling speed and agility. Key modules include Trial Rescue & Recovery (for struggling trials), Data Sciences & Biometrics, Clinical Monitoring (with Beeline portal for real-time visibility), Safety & Pharmacovigilance, AI-Powered Feasibility, and Quality Assurance. The company specializes in dermatology, oncology, nephrology, neurology, and cell therapy therapeutic areas. Additional offerings include the Few & Far Between podcast series and strategic partnerships with IBM Watson Health and Ryght AI for enhanced capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Few & Far Between Podcast: A podcast hosted by Melissa Alesse featuring conversations with biotech leaders and industry experts on drug development innovations.
- Beeline
- TALOS
Products and services
- Clinical Trial Management (Full-Service CRO) End-to-end full-service contract research organization (CRO) offering providing comprehensive clinical trial management and execution from first-in-human to proof-of-concept, powered by the proprietary TALOS project management system, for biotech and biopharma sponsors.
- Trial Rescue & Recovery Swift, strategic intervention service to put faltering clinical trials back on track, including restructuring site oversight, activating new sites, and accelerating patient enrollment, for sponsors with at-risk studies.
- Data Sciences & Biometrics Quality data solutions from design to delivery, including statistical analysis, data management, and real-world evidence generation, for sponsors needing clinical biometrics and data science capabilities.
- Clinical Monitoring Fit-for-purpose clinical monitoring combining advanced analytics, hands-on expertise, therapeutic insight, and site-level relationships, with the Beeline portal providing real-time sponsor visibility.
- Safety & Pharmacovigilance End-to-end safety management including 24/7 medical monitoring, AE/SAE case processing, signal detection, and regulatory submissions, using validated safety databases like Oracle Argus.
- AI-Powered Feasibility Dynamic site modeling, feasibility outreach, and real-time enrollment forecasting integrating AI data, operational discipline, and patient access insights, featuring AI-driven feasibility via the Ryght AI partnership.
- Quality Assurance Quality management services ensuring compliance with GCP standards and regulatory requirements across clinical trials, with documented 100% audit/inspection pass rate across sponsor programs.
- Therapeutic Expertise Services (Dermatology, Oncology, Nephrology, Neurology, Cell Therapy) Specialized clinical trial expertise in dermatology, oncology, nephrology, neurology, and cell therapy, organized as dedicated Centers of Excellence with therapeutic-area experts, for sponsors developing therapies in these complex areas.
Quantifiable outcome
- 5 FDA approvals achieved in the last 7 years
- +5 more outcomes
Companies that use Biorasi
Customer profileNamed customers6 records
Segments1 record
Ideal customer profiles2 records
Biorasi technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability6 records
Feature5 records
Biorasi partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Quotient SciencescoreStrategic partnership to provide integrated early phase clinical trial solutions combining Quotient's expertise in clinical development with Biorasi's global patient recruitment capabilities. The partnership aims to streamline drug development processes from IND to proof-of-concept within first-in-human trials, supporting sponsors with a single-provider model and expanded access to patient networks.
- IBM Watson HealthcorePreferred vendor partnership using IBM's Clinical Development (ICD) platform - a single-instance, fully-integrated SaaS clinical data management system. Biorasi reduced database build time by 25% and overall project costs by more than half by leveraging ICD's capabilities. The platform provides 24/7 access to data via single URL from any web-enabled device.
- Ryght AIcoreStrategic partnership to bring advanced AI-driven feasibility capabilities including dynamic AI digital twins of global research sites, automated feasibility forms cutting feasibility cycles to under 3 weeks, and agentic copilots for protocol parsing and automated document generation.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Biorasi competitors and assessment
Company assessmentDirect peers
- Premier Research: Specialty CRO focused on rare disease, oncology, and neuroscience for small-to-mid biopharma. Direct peer in therapeutic area, sponsor size, and complex-trial positioning.
- Ergomed: PE-backed specialty CRO (acquired by Permira) with strong rare disease and oncology focus. Comparable in scale, therapeutic specialization, and PE-backed growth posture.
- Medpace: Mid-to-large full-service CRO focused on complex, scientifically-driven trials for small and mid-sized biopharma sponsors. Highly comparable to Biorasi in therapeutic specialization, sponsor profile, and emphasis on quality execution.
- Worldwide Clinical Trials: Mid-sized global CRO with therapeutic specialization in neuroscience, cardiometabolic, and rare disease. Directly comparable to Biorasi in scale, therapeutic focus, and biotech/biopharma sponsor base.
- Novotech: Asia-Pacific-headquartered mid-sized CRO with strong biotech/biopharma focus. Comparable in mid-tier scale and biotech sponsor profile, with overlapping geographic and therapeutic focus.
Regional players
- Tigermed: China-based leading CRO serving biotech and biopharma sponsors. Comparable in clinical trial services but primarily serves Asia-Pacific with different geographic center of gravity.
Broad incumbents
- ICON plc: Global top-tier CRO offering comprehensive clinical and consulting services. Competes with Biorasi in full-service trial management but at vastly larger scale with broader therapeutic and geographic reach.
- Parexel: Large full-service CRO with broad therapeutic coverage. Comparable in clinical trial management services but operates at significantly larger scale with broader biopharma sponsor base.
- Syneos Health: Large biopharmaceutical solutions organization (now private under Elliott Investment Management post-take-private). Comparable in full-service CRO offerings and biotech/biopharma sponsor base, but at much larger scale.
- IQVIA: Largest global CRO with integrated technology, data, and clinical services. Represents the top end of Biorasi's competitive set, especially in preferred-vendor mega-deals with large biopharma.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Biorasi social profiles
Digital presenceBiorasi compliance and trust
Trust signalCompliance9 records
Biorasi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biorasi leadership team
Management profileNumber of profiles
Profiles13 records
Biorasi subsidiaries and ownership
Company hierarchySubsidiaries2 records
Biorasi funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biorasi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biorasi
What does Biorasi do?
Biorasi is a full-service contract research organization (CRO) that manages and executes complex clinical trials for small biotech and mid-sized biopharma sponsors. It delivers end-to-end services — including trial rescue, clinical monitoring, data sciences, safety and pharmacovigilance, feasibility, and quality assurance — powered by its proprietary TALOS project management system and Beeline real-time sponsor portal. The company specializes in neurology, nephrology, dermatology, oncology, and cell therapy.
Is Biorasi a public or private company?
Biorasi is a private company. It is classified as private equity controlled and is currently operating.
When was Biorasi founded?
Biorasi was founded in 2002. It employs 101 to 250 people.
Where is Biorasi based?
Biorasi is headquartered in Hollywood, United States, in the North America region.
How does Biorasi make money?
One revenue line is on record: contract Research Organization Services.
Who are Biorasi's main competitors?
Direct peers on record are Premier Research, Ergomed, Medpace, Worldwide Clinical Trials and Novotech. Tigermed is listed as a regional player. Broad incumbents are ICON plc, Parexel, Syneos Health and IQVIA.
Does Biorasi have an API?
No public API is recorded for Biorasi.
What industry is Biorasi in?
Biorasi's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.